age-related macular degeneration: Age-related loss of vision in the central portion of the retina (macula), secondary to retinal degeneration.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
845 |
4. Check minimum number of eventsNone |
845 |
5. Include endpointsNone |
845 |
6. Filter based on genotype QC (FinnGen only) |
845 |
Control definitions (FinnGen only)
- Control exclude
- H7_CHOROIDRETINA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H35
- Name in latin
- Haemorrhagia retinae
Similar endpoints
↥List of similar endpoints to
Retinal haemorrhage
based on the number of shared cases.
Similar with more cases:
- Other retinal disorders
- Disorders of choroid and retina
- Bleeding
- Diseases of the eye and adnexa
- Any operation in hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6470 | 3761 | 2664 |
| Only index persons | 5746 | 3425 | 2321 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.11 | 0.07 |
| Only index persons | 0.11 | 0.13 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 71.27 | 74.94 | 66.17 |
| Only index persons | 71.43 | 75.09 | 66.04 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 845 | 448 | 397 |
| Unadjusted period prevalence (%) | 0.16 | 0.15 | 0.18 |
| Median age at first event (years) | 67.98 | 67.63 | 68.37 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 743
- Matched controls
- 7431
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H35.6
ICD-10 Finland
Retinal haemorrhage
+∞
323.0
719
*
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1194.7
264.6
243
*
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
315.7
211.9
206
9
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
19.9
151.3
240
174
H43.1
ICD-10 Finland
Vitreous haemorrhage
91.5
145.5
159
22
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
20.3
115.6
179
114
XCW99
NOMESCO Finland
Other investigative procedure of eye
10.4
111.9
242
328
CKC12
NOMESCO Finland
Photocoagulation of retina
219.2
110.8
112
6
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
86.3
106.0
117
16
XCK10
NOMESCO Finland
Photography of fundus of eye
10.3
102.0
220
291
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
95.1
90.6
99
12
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
252.2
88.5
89
*
WX140
NOMESCO Finland
Parabulbar anesthesy
19.4
86.0
134
83
XCD20
NOMESCO Finland
Photoangiography of eye
294.1
79.1
79
*
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
281.6
75.9
76
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
+∞
68.8
65
*
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
357.5
66.6
66
*
CKC10
NOMESCO Finland
Local photocoagulation of retina
+∞
58.1
55
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
3.6
56.6
392
1777
CKD40
NOMESCO Finland
Endophotocoagulation of retina
567.2
54.2
53
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
47.4
53.6
65
15
H34.8
ICD-10 Finland
Other retinal vascular occlusions
+∞
50.6
48
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.4
48.8
208
607
H3603, E103
ICD-10 Finland
NA
+∞
46.3
44
*
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
475.4
45.8
45
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
4.2
42.9
190
567
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
39.8
41.5
52
14
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.9
40.6
356
1773
H33.3
ICD-10 Finland
Retinal breaks without detachment
+∞
38.9
37
*
CK9F4
NOMESCO Finland
Fluorescein angiography (FAG) of choroid and retina
+∞
37.8
36
*
A10AA01
ATC
NA
19.8
37.6
57
31
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
12.0
37.5
70
64
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
5.5
37.1
118
247
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
+∞
35.7
34
*
H43.8
ICD-10 Finland
Other disorders of vitreous body
5.2
35.3
117
256
CKW99
NOMESCO Finland
Other operation on choroid, vitreous body and retina
363.5
35.2
35
*
A10AA02
ATC
NA
10.4
33.0
66
69
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
10.7
33.0
65
66
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
30.3
32.4
43
15
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.3
31.0
124
328
H36.01
ICD-10 Finland
Diabetic maculopathy
166.9
30.9
32
*
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
114.9
30.9
33
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.1
30.7
103
227
H3603, E113
ICD-10 Finland
NA
+∞
30.4
29
*
T89
ICPC
Diabetes insulin dependent
9.8
29.7
61
67
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
12.3
29.6
54
47
A10AE04
ATC
insulin glargine; parenteral
4.2
28.8
117
313
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
50.7
28.6
34
7
H26.4
ICD-10 Finland
After-cataract
3.8
27.7
130
395
CKD15
NOMESCO Finland
Injection of vitreous substitute
+∞
27.2
26
*
H04AA01
ATC
glucagon; nasal, parenteral
17.3
26.1
41
25
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
96.9
25.8
28
*
H36.00
ICD-10 Finland
Diabetic background retinopathy
96.9
25.8
28
*
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
46.1
25.7
31
7
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
11.3
24.9
47
44
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
258.3
24.8
25
*
CKC15
NOMESCO Finland
Panretinal photocoagulation
258.3
24.8
25
*
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
93.3
24.8
27
*
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
43.0
23.8
29
7
ZXA10
NOMESCO Finland
Bilateral
2.7
23.5
194
866
XCK00
NOMESCO Finland
Perimetry
4.4
23.1
87
215
XCH00
NOMESCO Finland
Eye pressure measurement
6.1
22.9
64
113
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
22.0
21
*
H3600, E113
ICD-10 Finland
NA
+∞
22.0
21
*
H35.7
ICD-10 Finland
Separation of retinal layers
+∞
22.0
21
*
H3600, E103
ICD-10 Finland
NA
+∞
22.0
21
*
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
64.5
22.0
25
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
34.9
21.2
27
8
H3601, E103
ICD-10 Finland
NA
+∞
20.9
20
*
CM2X4
NOMESCO Finland
Follow-up OCT of age-related macular degeneration lesions
+∞
20.9
20
*
ZX198
NOMESCO Finland
Other local administration
43.0
20.6
25
6
XCD10
NOMESCO Finland
Electrophysiological examination of eye
8.0
20.1
46
61
H35.8
ICD-10 Finland
Other specified retinal disorders
+∞
19.9
19
*
A10AE06
ATC
insulin degludec; parenteral
9.8
19.8
40
43
Z3229
NOMESCO Finland
Other healthcare associate professional
3.5
19.4
98
313
S01ED51
ATC
timolol, combinations; ophthalmic
3.6
19.3
92
281
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
18.9
214
1111
CK9G4
NOMESCO Finland
Iridocyanine green angiography (ICGA) of choroid and retina
+∞
18.8
18
*
H36.09*E11.3
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic retinopathy
+∞
18.8
18
*
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
+∞
18.8
18
*
A10AE05
ATC
insulin detemir; parenteral
4.4
18.4
68
165
1LA05
NOMESCO Finland
NA
+∞
17.8
17
*
H25.8
ICD-10 Finland
Other senile cataract
2.8
17.7
126
507
CKD20
NOMESCO Finland
Removal of vitreous body substitute
184.1
17.6
18
*
ZXA05
NOMESCO Finland
Left side
2.2
17.1
228
1267
H53.1
ICD-10 Finland
Subjective visual disturbances
4.0
16.8
69
185
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
16.8
16.6
26
16
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
16.5
475
3543
C08CA01
ATC
amlodipine; oral
2.0
16.3
309
1976
H33.5
ICD-10 Finland
Other retinal detachments
30.8
16.2
21
7
103
Kela drug reimbursment
Diabetes, insulin-treated
2.1
16.0
237
1371
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.0
16.0
66
178
AA1AD
NOMESCO Finland
CT of head and brain
2.1
15.9
216
1204
H3601, E113
ICD-10 Finland
NA
+∞
15.7
15
*
H35.4
ICD-10 Finland
Peripheral retinal degeneration
+∞
15.7
15
*
H33.4
ICD-10 Finland
Traction detachment of retina
+∞
15.7
15
*
H25.1
ICD-10 Finland
Senile nuclear cataract
2.0
15.0
247
1482
E10
ICD-10 Finland
Type 1 diabetes mellitus
15.4
15.0
24
16
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
14.9
329
2202
H53.4
ICD-10 Finland
Visual field defects
7.1
14.8
36
53
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
11.7
14.4
26
23
ZXA00
NOMESCO Finland
Right side
2.0
14.0
231
1382
37701
ICD-8 Finland
Other diseases of retina and optic nerve, Haemorrhagia retinae et chorioideae
+∞
13.6
13
*
137
Kela drug reimbursment
Uraemia requiring dialysis
16.6
13.5
21
13
H35.37
ICD-10 Finland
Macular holes
142.4
13.5
14
*
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
6.4
13.5
35
57
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
21.6
13.4
19
9
Z49.2
ICD-10 Finland
Other dialysis
17.1
13.0
20
12
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.0
12.9
180
1004
H35.9
ICD-10 Finland
Retinal disorder, unspecified
132.1
12.5
13
*
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
11.9
12.4
22
19
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
12.4
342
2416
C03CA01
ATC
furosemide; systemic
1.8
12.3
272
1791
127
Kela drug reimbursment
Transplant complication
8.4
12.1
26
32
B05DA
ATC
Isotonic solutions
18.4
12.1
18
10
WX142
NOMESCO Finland
Sub-tenon anesthesy
27.2
12.1
16
6
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.1
12.1
32
54
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
21.7
12.0
17
8
B03XA02
ATC
darbepoetin alfa; parenteral
6.8
11.8
29
44
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
30.6
11.7
15
5
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
66.0
11.6
13
*
H31.3
ICD-10 Finland
Choroidal haemorrhage and rupture
+∞
11.5
11
*
H33.2
ICD-10 Finland
Serous retinal detachment
+∞
11.5
11
*
3628A
ICD-9 Finland
Other retinal disorders[HAEMORRHAGIA RETINAE]
+∞
11.5
11
*
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
+∞
11.5
11
*
CK2M4
NOMESCO Finland
Macular light layer imaging (OCT)
+∞
11.5
11
*
CK2Y4
NOMESCO Finland
OCT video recording of ocular fundus
121.8
11.5
12
*
ZXD05
NOMESCO Finland
Urgent procedure
1.8
11.3
242
1565
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
25.4
11.2
15
6
WX002
NOMESCO Finland
Sedation and analgesia
2.0
11.2
164
926
S01BC05
ATC
ketorolac; ophthalmic
3.5
11.0
52
158
S01EC01
ATC
acetazolamide; systemic
5.3
11.0
33
65
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
18.1
10.8
16
9
205
Kela drug reimbursment
Chronic hypertension
1.8
10.6
246
1626
F29
ICPC
Eye symptom/complaint other
2.8
10.4
66
248
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
5.9
10.3
28
49
C02AC05
ATC
moxonidine; oral
3.3
10.3
51
162
TK800
NOMESCO Finland
Hemodialysis
5.7
10.0
28
51
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
17.0
9.9
15
9
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
5.6
9.9
28
52
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.8
9.7
40
109
A10AA03
ATC
NA
8.5
9.6
20
24
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
9.6
90
419
177
Kela drug reimbursment
Insulin glargine 300 U / ml
7.3
9.6
22
31
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
17.8
9.4
14
8
CM2S4
NOMESCO Finland
Follow-up photography of age-related macular degeneration lesions
+∞
9.4
9
*
H3602, E103
ICD-10 Finland
NA
+∞
9.4
9
*
H34.1
ICD-10 Finland
Central retinal artery occlusion
+∞
9.4
9
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
2.2
9.4
102
507
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
9.4
104
521
A12AA04
ATC
calcium carbonate; oral
7.0
9.4
22
32
H53.9
ICD-10 Finland
Visual disturbance, unspecified
4.1
9.3
35
88
H16.0
ICD-10 Finland
Corneal ulcer
3.8
9.1
38
105
H26.2
ICD-10 Finland
Complicated cataract
8.4
9.1
19
23
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
24.3
8.9
12
5
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.6
8.9
39
113
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.1
8.9
19
24
V03AE01
ATC
polystyrene sulfonate; oral
9.6
8.8
17
18
N02BE01
ATC
paracetamol; systemic, rectal
1.8
8.7
614
5408
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
8.7
257
1801
WW500
NOMESCO Finland
Blood transfusion
3.3
8.5
41
128
C09CA01
ATC
losartan; oral
1.7
8.4
186
1199
C09AA02
ATC
enalapril; systemic
1.8
8.3
168
1051
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
10.9
8.3
15
14
S01BC03
ATC
diclofenac; ophthalmic
4.3
8.3
29
69
A11CC03
ATC
alfacalcidol; systemic
4.6
8.2
27
60
B05DB
ATC
Hypertonic solutions
14.7
8.2
13
9
H25.0
ICD-10 Finland
Senile incipient cataract
2.6
8.0
58
235
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
8.0
209
1413
C07AB07
ATC
bisoprolol; oral
1.6
7.9
364
2832
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.0
7.9
43
148
J01DB01
ATC
cefalexin; oral
1.6
7.8
559
4834
A98
ICPC
Health maint/preventive medicine
1.9
7.8
664
6047
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
7.8
56
225
WX110
NOMESCO Finland
Local anesthesy
1.5
7.7
443
3626
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.7
7.7
52
203
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
18.6
7.6
11
6
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
7.5
76
364
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
3.7
7.4
31
87
CKC20
NOMESCO Finland
Cryopexy of undetached retina
80.8
7.4
8
*
H34.2
ICD-10 Finland
Other retinal artery occlusions
80.8
7.4
8
*
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.8
7.4
16
21
Z94.0
ICD-10 Finland
Kidney transplant status
8.5
7.3
15
18
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
6.9
7.3
17
25
T90
ICPC
Diabetes non-insulin dependent
1.7
7.2
171
1119
S18
ICPC
Laceration/cut
1.5
7.2
293
2200
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
20.2
7.1
10
5
H57.1
ICD-10 Finland
Ocular pain
3.8
7.1
28
75
SPAT1262
SPAT
Handing over of treatment supplies
1.8
7.1
137
839
SPAT1325
SPAT
Vaccination
1.6
7.1
258
1886
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.8
7.0
28
76
L04AD01
ATC
ciclosporin; systemic
5.0
7.0
21
43
L04AA06
ATC
mycophenolic acid; systemic
5.9
6.9
18
31
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
13.9
6.9
11
8
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
6.9
60
271
H40.0
ICD-10 Finland
Glaucoma suspect
2.3
6.8
59
265
CKC60
NOMESCO Finland
Local buckling of sclera using implant
40.4
6.8
8
*
C10AA05
ATC
atorvastatin; oral
1.5
6.8
280
2102
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.2
6.7
24
59
J01MA12
ATC
levofloxacin; systemic
1.7
6.7
134
832
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
22.7
6.7
9
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
6.5
6.7
16
25
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
6.9
6.5
15
22
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
6.5
65
312
J01FF01
ATC
clindamycin; systemic
1.6
6.5
178
1209
WZC30
NOMESCO Finland
Teaching
1.9
6.4
95
535
CKD50
NOMESCO Finland
Endodiathermy of retina
70.4
6.4
7
*
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
70.4
6.4
7
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.7
6.4
131
817
TK820
NOMESCO Finland
Peritoneal dialysis
14.5
6.4
10
7
V03AE02
ATC
sevelamer; oral
14.5
6.4
10
7
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.6
6.4
27
78
R51.80
ICD-10 Finland
Headache
1.9
6.3
94
530
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.0
6.3
16
27
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.9
6.3
24
63
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
11.1
6.3
11
10
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.5
6.3
27
79
H28.0
ICD-10 Finland
Diabetic cataract
+∞
6.3
6
*
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
7.1
6.2
14
20
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
6.2
72
369
J05AB01
ATC
aciclovir; systemic
1.7
6.2
137
874
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
6.1
130
818
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
4.7
6.1
19
41
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.1
180
1242
WW200
NOMESCO Finland
Immunization
3.2
6.1
29
92
Z3231
NOMESCO Finland
Registered nurse
1.6
6.1
189
1320
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.6
6.1
177
1220
S01EA03
ATC
apraclonidine; ophthalmic
6.8
6.1
14
21
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
6.0
171
1167
J01CF05
ATC
flucloxacillin; systemic
3.0
6.0
32
110
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013826) Glucose [Moles/volume] in Serum or Plasma
565
4039
2.20
25.21
8.0
4.8
mmol/l
7.5
6.8
6.14
538
3795
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
491
3532
1.93
18.99
11.5
6.5
mmol/l
1.2
1.2
1.60
408
2976
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
40
89
4.67
16.97
1.9
1.3
u/ml
101.7
113.4
0.38
12
14
(3018677) aPTT in Platelet poor plasma by Coagulation assay
199
1102
2.05
16.14
2.8
1.9
s
29.8
29.9
0.07
192
1067
(3032080) INR in Blood by Coagulation assay
416
2936
1.82
16.07
11.6
10.3
inr
1.4
1.3
1.08
111
801
(3012516) Albumin [Mass/volume] in Urine
310
1999
1.87
16.04
4.0
3.1
mg/l
241.5
262.5
0.04
199
1277
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
340
2293
1.81
14.97
3.6
3.1
ng/l
2076.6
1629.9
0.75
297
1983
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
443
3249
1.76
14.48
11.6
5.8
mmol/l
1.2
1.2
1.37
393
2933
(3009508) Creatinine [Moles/volume] in Urine
316
2102
1.80
14.45
4.1
3.0
mmol/l
6.6
7.4
2.62
247
1753
(3003458) Phosphate [Moles/volume] in Serum or Plasma
172
938
2.05
14.40
11.8
4.9
mmol/l
1.1
1.0
4.62
164
852
(42870588) Differential panel, method unspecified - Blood
329
2223
1.79
14.21
8.3
5.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
39
98
4.12
14.20
1.8
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
317
2126
1.79
14.00
5.0
3.7
mg/mmol
17.2
8.2
1.59
205
1342
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
26
47
5.68
13.90
1.3
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
316
2126
1.78
13.75
2.4
2.1
u/l
273.4
245.8
0.10
296
2000
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
630
5190
1.84
13.15
11.1
7.3
u/l
86.4
79.6
1.77
597
4844
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
385
2766
1.72
13.11
4.7
3.9
ng/l
48.0
54.6
0.18
309
2035
(3023368) Bacteria identified in Blood by Culture
305
2060
1.75
12.91
6.1
4.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
40
110
3.77
12.88
7.0
5.6
iu/ml
6421.7
235.1
—
7
19
(3024471) HLA-A [Type]
14
13
10.93
12.88
1.0
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
768
6800
2.42
12.78
29.2
18.5
mmol/l
139.3
139.6
2.74
755
6615
(3022217) INR in Platelet poor plasma by Coagulation assay
173
983
1.96
12.77
38.0
26.9
inr
1.3
1.4
0.28
26
124
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
26
51
5.23
12.75
2.6
2.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
769
6815
2.43
12.73
29.9
18.7
mmol/l
4.0
4.0
2.56
753
6623
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
229
1436
1.82
12.41
2.0
1.7
mg/l
1.4
1.3
0.08
183
1120
(3006315) Basophils [#/volume] in Blood
436
3274
1.69
12.34
7.2
5.3
e9/l
0.0
0.0
0.04
389
2812
(3019198) Lymphocytes [#/volume] in Blood
442
3333
1.68
12.29
7.4
5.4
e9/l
2.1
1.9
0.50
403
2908
(3013115) Eosinophils [#/volume] in Blood
446
3374
1.68
12.23
7.9
5.6
e9/l
0.2
0.2
0.10
400
2947
(3001604) Monocytes [#/volume] in Blood
434
3261
1.68
12.20
7.2
5.3
e9/l
0.6
0.6
1.36
387
2789
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
747
6569
2.18
12.14
24.5
15.7
mg/l
25.9
25.7
0.04
625
5261
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
271
1810
1.73
11.71
2.7
2.2
mg/l
2.8
3.1
1.23
235
1527
(3024932) HLA-DR beta [Type]
13
13
10.14
11.36
1.0
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
186
1123
1.84
11.28
4.0
2.3
umol/l
12.5
12.5
0.00
171
1034
(3020779) Urea [Moles/volume] in Serum or Plasma
119
617
2.08
11.26
15.4
6.2
mmol/l
12.0
10.3
1.74
113
581
(3037467) Urinalysis macro (dipstick) panel - Urine
573
4685
1.69
11.22
5.4
4.5
—
—
—
0
0
(3000991) Gas panel - Venous blood
118
612
2.08
11.16
12.6
7.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
309
2161
1.68
11.15
4.4
2.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
12
11
11.05
11.08
1.5
1.0
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
463
3598
1.63
10.94
9.2
6.0
umol/l
11.2
12.0
0.75
433
3422
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
701
6096
1.88
10.75
21.6
14.8
ml/min/173m2
72.3
76.3
4.15
607
5020
(3004789) Transferrin [Mass/volume] in Serum or Plasma
171
1023
1.84
10.62
4.0
2.3
g/l
2.2
2.3
0.83
159
937
(3013707) Erythrocyte sedimentation rate by Westergren method
592
4915
1.68
10.60
4.9
4.1
mm/h
16.1
13.6
2.91
547
4495
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
96
3.65
10.57
1.7
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
404
3065
1.61
10.31
8.7
5.8
%
8.7
8.7
0.05
386
2857
(3013650) Neutrophils [#/volume] in Blood by Automated count
484
3835
1.61
10.31
12.2
8.6
e9/l
4.5
4.2
1.77
444
3351
(3002030) Lymphocytes/100 leukocytes in Blood
410
3122
1.61
10.30
8.5
5.7
%
26.2
27.1
0.69
391
2895
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
142
808
1.91
10.29
6.8
4.0
u/l
287.0
251.2
1.01
135
755
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
393
2966
1.61
10.22
2.3
2.1
pmol/l
92.6
94.9
0.45
211
1497
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
10
11.13
10.18
1.5
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
33
94
3.61
10.13
1.8
1.2
u/ml
221.2
282.2
0.52
26
55
(3001122) Ferritin [Mass/volume] in Serum or Plasma
367
2730
1.61
10.10
4.0
2.7
ug/l
168.0
134.4
0.72
336
2489
(3026493) Urate [Moles/volume] in Serum or Plasma
256
1743
1.67
10.03
3.9
2.7
umol/l
3365.9
7835.1
1.09
217
1486
(3018095) Leukocytes [#/volume] in Urine
340
2487
1.61
10.01
4.8
3.9
e6/l
119.2
121.5
0.01
257
1798
(21494434) Karyotype in Bone marrow
26
63
4.23
9.95
1.5
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
346
2549
1.61
9.85
4.6
3.3
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
719
6352
1.88
9.81
5.3
4.4
mmol/l
4.3
4.6
7.97
645
5814
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
766
6922
2.14
9.68
15.3
10.4
u/l
24.5
25.4
1.01
734
6647
(3012095) Magnesium [Moles/volume] in Serum or Plasma
179
1115
1.77
9.65
5.6
3.1
mmol/l
0.8
0.8
0.80
172
1029
(3036489) Thrombin time
56
224
2.61
9.64
3.4
2.1
s
20.8
21.8
0.77
49
205
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
161
974
1.81
9.57
4.2
2.4
%
22.7
22.0
0.24
138
825
(3006504) Eosinophils/100 leukocytes in Blood
399
3058
1.58
9.49
8.3
5.5
%
2.8
2.8
0.21
381
2839
(3020891) Body temperature
66
288
2.40
9.47
8.8
4.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
683
5964
1.76
9.40
5.5
4.7
mu/l
2.0
2.2
0.49
614
5373
(3022096) Basophils/100 leukocytes in Blood
390
2982
1.57
9.32
8.3
5.5
%
0.6
0.6
0.18
371
2776
(3027945) Reticulocytes/100 erythrocytes in Blood
147
873
1.83
9.27
4.6
2.3
%
1.8
1.8
0.09
130
784
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
45
164
2.84
9.26
2.9
2.3
ug/min
66.9
92.3
0.33
29
94
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
729
6508
1.88
9.07
5.9
5.0
mmol/l
2.5
2.7
7.96
651
5908
(3031040) Bacteria [#/volume] in Urine by Automated count
551
4577
1.59
9.02
5.9
4.8
e6/l
3.7
3083.5
—
6
77
(3007461) Platelets [#/volume] in Blood
785
7196
2.28
8.99
35.5
22.8
e9/l
239.3
245.1
1.47
770
6994
(3024731) MCV [Entitic volume]
785
7197
2.28
8.97
35.4
22.8
fl
91.3
91.4
0.15
777
7065
(3018418) pH of Serum or Plasma
293
2111
1.59
8.96
8.2
3.9
ph
7.4
7.4
0.14
52
397
(3035941) MCH [Entitic mass]
785
7198
2.28
8.95
35.3
22.7
pg
30.2
30.4
1.02
777
7066
(3026361) Erythrocytes [#/volume] in Blood
785
7199
2.27
8.93
35.5
22.8
e12/l
4.3
4.4
4.28
767
6976
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
239
1640
1.64
8.92
3.9
2.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
785
7200
2.27
8.91
35.5
22.9
e9/l
7.2
6.8
1.67
762
6979
(3000963) Hemoglobin [Mass/volume] in Blood
785
7201
2.27
8.89
35.8
23.0
g/l
130.1
133.6
7.80
777
7064
(3002582) Erythrocytes [#/volume] in Urine
297
2151
1.59
8.86
4.3
3.4
e6/l
43.8
99.6
0.96
248
1676
(3023520) Reticulocytes [#/volume] in Blood
115
640
1.92
8.86
4.9
2.3
e9/l
68.3
67.9
0.04
97
501
(3005719) IgG [Mass/volume] in Serum or Plasma
92
475
2.05
8.77
3.3
2.7
g/l
9.6
10.7
1.62
81
427
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
690
6081
1.73
8.70
8.3
5.9
mmol/mol
43.9
40.1
11.75
618
5581
(3002032) Base excess in Venous blood by calculation
124
715
1.86
8.56
7.3
3.3
mmol/l
2.0
2.2
0.19
105
562
(3018010) Neutrophils/100 leukocytes in Blood
395
3076
1.53
8.41
7.9
5.4
%
58.7
57.7
0.71
374
2874
(3042936) Bacteria identified in Isolate by Culture
159
993
1.74
8.41
2.9
2.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
275
1983
1.57
8.24
4.3
3.3
e6/l
0.6
0.5
0.13
221
1511
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
188
1236
1.67
8.22
3.1
2.9
e6/l
1.0
1.1
0.17
120
722
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
20
46
4.43
8.18
1.3
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
706
6301
1.73
8.02
5.4
4.4
mmol/l
1.4
1.5
2.24
630
5728
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
686
6081
1.68
7.93
4.9
4.0
mmol/l
1.3
1.3
0.45
604
5485
(3028026) IgM [Mass/volume] in Serum or Plasma
76
380
2.10
7.89
2.8
1.7
g/l
2.1
1.5
0.37
61
342
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
114
659
1.84
7.79
2.8
2.6
ug/l
6.2
6.4
0.07
102
565
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
95
519
1.94
7.72
2.6
2.7
ml/min/173m2
54.3
63.0
1.41
47
216
(3019309) Folate [Moles/volume] in Red Blood Cells
213
1466
1.61
7.70
1.8
1.8
nmol/l
1213.1
1204.5
0.04
161
1089
(40768804) Tissue Pathology biopsy report
336
2565
1.51
7.64
2.0
2.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
304
2272
1.53
7.64
3.5
3.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
12
18
6.75
7.62
2.3
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
102
573
1.89
7.62
4.3
3.5
ng/l
114.3
85.7
1.22
90
496
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
395
3133
1.49
7.38
6.8
4.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
7
0
+∞
7.30
1.9
0.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
7
0
+∞
7.30
1.9
0.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
26
79
3.36
7.29
1.8
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
261
1906
1.53
7.22
4.4
3.3
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
34
4.78
7.18
1.5
1.3
—
—
—
0
0
(3019225) pH of Specimen
116
692
1.78
7.14
6.4
4.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
216
1516
1.57
7.12
3.6
2.6
e6/l
5.5
5.8
0.09
187
1336
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
71
361
2.06
7.06
2.2
1.7
g/l
1.4
1.6
1.43
60
317
(3024561) Albumin [Mass/volume] in Serum or Plasma
388
3086
1.48
7.05
7.3
4.5
g/l
34.4
35.0
1.13
358
2841
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
82
444
1.94
6.84
4.0
3.8
mmol/l
1.4
2.1
0.98
59
335
(3035350) Ketones [Presence] in Urine by Test strip
405
3263
1.46
6.80
4.9
3.8
estimate
0.0
0.0
0.00
75
606
(3009261) Glucose [Presence] in Urine by Test strip
408
3293
1.46
6.79
5.0
3.9
estimate
0.0
0.0
0.00
74
594
(3048929) Epstein Barr virus Ab [Presence] in Serum
37
144
2.64
6.78
1.7
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
40
4.32
6.77
1.2
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
570
4912
1.49
6.74
4.4
3.8
pmol/l
15.1
15.0
0.94
502
4392
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
184
1261
1.59
6.68
2.1
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
128
801
1.70
6.65
2.3
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
403
3257
1.45
6.59
6.2
5.2
estimate
0.0
0.0
0.00
73
606
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
57
274
2.16
6.56
2.1
1.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
281
2124
1.48
6.46
4.4
2.4
u/l
60.5
57.9
0.20
251
1955
(3011397) Hemoglobin [Presence] in Urine by Test strip
218
1563
1.53
6.46
4.8
3.8
—
—
—
0
0
(3026782) Osmolality of Urine
201
1419
1.55
6.38
3.9
2.8
mosm/kgh2o
526.9
556.7
1.12
169
1211
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
135
867
1.66
6.36
8.9
7.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
342
2693
1.45
6.35
2.8
2.2
nmol/l
80.5
78.5
0.55
303
2376
(3009343) pH of Capillary blood
83
463
1.88
6.34
4.3
3.8
ph
7.4
7.4
—
9
54
(40761511) CBC panel - Blood by Automated count
738
6773
1.71
6.26
22.1
14.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
243
1794
1.50
6.24
1.6
1.6
nmol/l
19.6
20.8
0.63
203
1520
(3017143) Hepatitis C virus Ab [Presence] in Serum
99
587
1.78
6.21
2.1
1.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
701
6364
1.60
6.06
5.4
4.7
mmol/l
6.4
6.0
6.56
615
5729
(3000093) Morphology [Interpretation] in Blood Narrative
20
58
3.51
6.04
1.1
1.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
103
624
1.74
6.00
3.8
3.0
g/l
66.3
66.0
0.09
91
565
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
59
298
2.05
6.00
2.2
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
27
95
2.90
5.99
1.2
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
67
361
1.93
5.69
8.5
3.3
mmol/l
24.2
24.5
0.23
56
325
(3029937) Albumin [Presence] in Urine by Test strip
238
1778
1.47
5.69
5.9
4.1
estimate
0.0
0.0
0.69
69
586
(3000494) Fungus identified in Specimen by Culture
122
786
1.65
5.66
2.1
1.4
—
—
—
0
0
(3013512) EKG study
268
2052
1.45
5.62
4.3
4.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
309
2435
1.42
5.52
3.5
3.3
mmol/l
2.3
2.4
0.26
261
2097
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
21
68
3.14
5.37
2.3
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
34
143
2.44
5.37
1.8
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
37
164
2.31
5.21
1.9
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
41
190
2.22
5.21
1.6
1.6
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
30
121
2.53
5.17
1.2
1.2
u/l
86.6
37.4
0.78
24
107
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
164
1157
1.52
5.14
3.3
3.1
e6/l
2.7
2.3
0.21
101
651
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
195
1428
1.48
5.09
5.2
4.0
ng/l
206.7
303.0
0.46
159
1172
(3004588) Protein electrophoresis panel - Serum or Plasma
86
524
1.71
4.92
3.4
2.7
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
79
471
1.75
4.88
4.9
2.9
g/l
124.3
127.5
0.69
79
460
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
104
668
1.64
4.88
2.2
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
63
351
1.86
4.86
5.8
3.5
%
48.2
48.8
0.07
63
346
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
51
265
1.98
4.84
4.6
2.5
u/ml
0.3
0.4
2.01
29
156
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
113
2.53
4.83
2.1
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
157
2.28
4.81
2.1
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
28
114
2.51
4.75
2.0
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
41
199
2.11
4.67
1.5
1.5
ug/g
254.7
284.2
0.42
27
118
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
12
29
4.18
4.64
1.3
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
164
1182
1.48
4.61
1.6
1.5
g/l
2.6
2.6
0.00
99
669
(3016650) Hepatitis A virus Ab [Presence] in Serum
25
98
2.60
4.58
1.2
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
120
810
1.56
4.58
1.3
1.3
titre
618.8
462.1
0.36
32
168
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
125
853
1.55
4.55
10.7
7.4
kpa
5.1
5.1
0.22
119
811
(40760892) CBC W Ordered Manual Differential panel - Blood
183
1352
1.45
4.52
5.6
4.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
125
854
1.54
4.52
10.7
7.4
kpa
11.3
11.8
0.73
119
814
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
24
93
2.63
4.50
2.3
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
91
581
1.63
4.38
2.2
1.9
nmol/l
385.2
377.7
0.12
83
525
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
97
630
1.61
4.36
4.3
2.5
u/l
34.7
108.6
0.48
82
538
(3021589) Normoblasts [#/volume] in Blood
348
2882
1.35
4.35
14.1
9.6
e9/l
0.0
0.0
0.61
292
2362
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
117
797
1.54
4.29
6.2
2.7
umol/l
10.5
9.0
0.23
103
696
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
83
522
1.65
4.24
2.1
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
118
808
1.54
4.22
2.3
1.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
27
4.11
4.17
1.5
1.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
15
47
3.23
4.07
1.9
1.8
—
35.7
—
0
6
(3003396) Base excess in Arterial blood by calculation
123
858
1.51
4.04
10.8
7.4
mmol/l
1.0
1.3
0.33
99
656
(3017817) Protein [Mass] in Urine collected for unspecified duration
19
69
2.79
4.04
2.4
2.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
29
130
2.27
4.03
1.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
48
3.16
3.94
1.5
1.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
416
3574
1.32
3.92
2.7
2.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
71
438
1.68
3.91
1.7
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
466
4079
1.32
3.80
3.7
3.1
u/l
58.0
50.5
0.79
420
3765
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
5
12.07
3.77
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
213
1668
1.37
3.71
1.8
1.6
mmol/l
1.3
1.4
0.40
177
1405
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
20
79
2.57
3.65
1.3
1.1
u/ml
5.7
1.6
—
6
24
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
116
821
1.48
3.55
5.0
4.6
%
34.1
32.5
0.83
83
528
(3042111) Morphology [Interpretation] in Bone marrow Narrative
27
125
2.20
3.51
3.7
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
58
350
1.71
3.49
4.0
4.0
—
—
—
0
0
(4035726)
88
593
1.54
3.40
1.7
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
61
376
1.67
3.40
1.6
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
46
262
1.80
3.38
2.7
2.1
ug/l
5336.5
477.5
0.48
46
250
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
9
18
5.04
3.37
1.2
2.5
%
161.4
148.9
—
9
18
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
27
3.74
3.36
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
27
3.74
3.36
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
21
89
2.39
3.34
2.0
2.0
u/l
240.0
5069.2
—
8
25
(3009445) Proteinase 3 Ab [Units/volume] in Serum
50
295
1.74
3.27
1.3
1.3
—
12.4
—
0
5
(3021901) Oxygen saturation in Capillary blood
28
136
2.10
3.25
3.9
2.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
34
178
1.95
3.23
2.2
1.6
e6/l
18390.5
16523.0
0.06
26
131
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
28
3.60
3.20
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
11
33
3.36
3.20
2.0
2.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
11
6.41
3.19
6.0
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
211
1689
1.33
3.14
10.2
6.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
9
20
4.54
3.12
2.1
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
138
1034
1.40
3.12
1.3
1.3
iu/ml
31.0
36.8
0.25
31
327
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
298
2504
1.29
3.11
5.6
4.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
99
2.25
3.08
1.2
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
19
80
2.41
3.08
1.2
1.1
u/ml
2.8
9.3
0.99
11
35
(3019060) Gas panel - Arterial blood
77
517
1.54
3.04
6.8
4.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
193
1535
1.33
2.99
1.9
1.7
pmol/l
86986724.7
9033213.1
0.43
146
1251
(3003181) Sodium [Moles/volume] in Urine
27
134
2.05
2.99
1.3
1.3
mmol/l
83.6
62.0
0.94
21
107
(4306422)
18
75
2.43
2.98
1.2
1.2
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
35
191
1.87
2.97
3.9
2.7
mmol/l
23.9
25.0
0.84
30
165
(3010421) pH of Blood
35
191
1.87
2.97
8.1
4.1
ph
7.4
7.4
0.02
27
149
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
50
305
1.68
2.93
2.4
2.0
ug/l
2.4
1.5
0.43
44
270
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
8
17
4.74
2.92
1.0
1.1
miu/ml
1870.6
1732.3
—
8
17
(3044889) 12 lead EKG panel
521
4720
1.27
2.87
5.1
4.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
120
891
1.40
2.86
2.0
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
284
1.69
2.85
4.5
2.8
g/l
11.3
10.1
0.68
40
244
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
36
201
1.83
2.85
1.7
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
116
2.10
2.85
7.0
3.2
%
57.5
59.2
0.20
24
116
(40761535) Cells panel - Urine sediment
85
592
1.48
2.84
4.8
3.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
18
77
2.37
2.83
1.1
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
23
110
2.12
2.81
8.9
3.6
%
2.2
1.2
0.56
16
91
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
16
65
2.49
2.80
1.1
1.2
u/l
121.9
65.4
—
9
48
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
35
195
1.83
2.80
2.4
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
14
5.03
2.73
2.6
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
120
900
1.39
2.70
2.1
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
19
4.24
2.68
1.5
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
91
654
1.44
2.61
2.5
2.1
g/l
0.2
0.2
0.27
86
608
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
94
2.15
2.56
1.3
1.2
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
143
1.92
2.53
6.7
3.9
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
10
33
3.05
2.53
2.1
3.5
%
114.6
97.0
—
10
33
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
36
210
1.75
2.50
1.3
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
28
151
1.88
2.49
8.3
4.6
mmol/l
2.1
2.5
0.30
20
99
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
248
2085
1.27
2.49
4.5
3.2
u/l
33.1
34.0
0.17
231
1971
(3017181) Myelocytes/100 leukocytes in Blood
78
550
1.46
2.48
6.6
4.0
%
1.6
0.9
0.63
30
171
(3037121) Protein [Mass/volume] in Urine
43
265
1.66
2.46
4.2
3.2
g/l
0.4
0.2
0.66
21
109
(3014765) Yersinia sp identified in Stool by Organism specific culture
36
212
1.73
2.43
1.3
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
625
5838
1.27
2.42
25.2
17.0
%
38.2
39.4
1.91
405
3916
(3002179) Metamyelocytes/100 leukocytes in Blood
71
495
1.47
2.39
7.0
4.0
%
1.1
0.5
0.81
22
123
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
42
260
1.65
2.37
3.5
3.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
118
1.98
2.37
16.0
2.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
27
147
1.86
2.35
1.7
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
38
230
1.68
2.34
1.4
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
29
162
1.82
2.34
3.6
2.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
36
215
1.70
2.32
1.3
1.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
35
2.88
2.31
7.5
13.4
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
10
35
2.88
2.31
2.5
2.1
nmol/l
23.0
20.9
—
10
30
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
278
1.61
2.30
4.8
2.9
g/l
3.0
3.2
0.57
38
223
(3004616) Nuclear Ab [Presence] in Serum
16
72
2.25
2.28
1.2
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
92
2.09
2.28
2.4
2.5
mg/l
20.7
26.6
—
6
21
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
47
2.58
2.28
1.6
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
32
186
1.75
2.27
1.6
1.6
iu/ml
0.4
28.9
—
9
42
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
35
209
1.70
2.26
1.5
1.7
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
18
3.91
2.25
2.4
1.5
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
69
485
1.46
2.24
9.8
6.9
mmol/l
24.7
24.4
0.27
64
454
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
9
29
3.13
2.23
1.3
1.7
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
9
5.58
2.21
1.2
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
34
203
1.70
2.21
3.6
3.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
10
36
2.80
2.20
1.8
1.2
mmol/l
2.1
1.9
—
10
36
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
13
54
2.43
2.20
1.1
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
27
151
1.81
2.18
1.9
1.4
iu/l
23.3
31.2
0.58
22
128
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
87
2.09
2.18
1.3
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
122
1.91
2.18
2.6
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
29
166
1.77
2.17
1.4
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
9
30
3.02
2.15
1.3
1.6
—
—
—
0
0
(4211845)
9
30
3.02
2.15
3.4
3.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
174
1426
1.28
2.13
3.0
3.0
mmol/l
2.5
2.5
0.03
154
1238
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
300
1.56
2.13
4.6
2.7
g/l
4.3
3.6
0.62
38
220
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
15
68
2.23
2.12
1.3
1.9
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
55
374
1.50
2.11
2.6
2.7
e6/l
0.3
0.4
0.19
55
363
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
301
1.56
2.10
4.6
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
301
1.56
2.10
4.6
2.7
g/l
7.4
7.5
0.19
38
227
(40768443) Skin Pathology biopsy report
44
286
1.57
2.07
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
10
5.02
2.07
1.2
1.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
10
5.02
2.07
1.2
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
139
1.82
2.07
1.5
1.3
—
—
—
0
0
(44806118)
17
83
2.07
2.02
2.2
1.5
—
—
—
0
0
(44790048)
17
83
2.07
2.02
2.2
1.5
—
—
—
0
0
(44790047)
17
83
2.07
2.02
2.2
1.5
—
—
—
0
0
(44790049)
17
83
2.07
2.02
2.2
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
32
2.83
2.00
4.1
4.8
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
32
2.83
2.00
2.4
2.0
u/ml
7208.3
1270.5
—
9
32
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
126
1000
1.31
1.98
1.2
1.3
u/ml
8.6
13.2
0.31
38
353
(3003694) ABO and Rh group [Type] in Blood
196
1646
1.25
1.95
1.4
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
64
2.21
1.95
2.3
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
79
586
1.38
1.94
11.3
3.8
mmol/l
1.2
1.2
0.06
65
519
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
33
2.75
1.93
1.3
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
38
244
1.58
1.90
4.9
2.8
g/l
38.4
37.3
0.66
32
209
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
114
1.86
1.88
1.7
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
28
2.87
1.86
3.8
3.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
159
1311
1.26
1.86
1.3
1.2
u/ml
0.7
1.9
2.10
45
339
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
17
3.55
1.84
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
17
3.55
1.84
1.2
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
91
697
1.34
1.84
3.4
3.1
ng/l
200.6
236.0
0.69
83
648
(40761536) Microorganisms panel - Urine sediment
74
549
1.38
1.82
5.8
3.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
15
73
2.07
1.81
1.3
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
87
1.97
1.81
1.7
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
35
2.59
1.80
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
23
3.06
1.80
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
25
146
1.73
1.79
1.2
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
105
826
1.31
1.77
1.2
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
54
2.24
1.74
1.1
1.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
70
519
1.38
1.74
6.2
4.0
%
0.2
0.1
0.15
28
156
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
13
3.86
1.71
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
39
259
1.53
1.71
4.8
3.1
g/l
2.3
1.1
0.64
34
225
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
10
42
2.40
1.68
1.3
1.4
—
392.5
—
0
8
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
16
83
1.95
1.65
2.0
1.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
63
2.08
1.60
1.1
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
57
416
1.40
1.57
2.9
3.2
e9/l
4.4
4.2
0.15
40
305
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
16
85
1.90
1.55
2.0
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
66
495
1.36
1.55
1.9
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
90
707
1.31
1.55
1.3
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
78
1.94
1.55
8.1
4.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
14
71
1.99
1.54
1.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
30
193
1.57
1.53
2.3
1.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
17
93
1.84
1.52
1.3
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
21
2.87
1.50
3.7
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
32
210
1.54
1.50
1.3
1.2
u/ml
1.3
1.9
—
7
15
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
101
1.80
1.49
1.3
1.5
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
14
72
1.96
1.49
6.1
3.7
%
51.0
54.6
—
7
54
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
37
2.45
1.48
1.3
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
289
0.58
1.43
1.5
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
9
39
2.32
1.43
2.9
2.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
258
2292
1.18
1.42
5.1
5.1
ug/l
2.4
2.6
0.20
229
2031
(3019150) Specific gravity of Urine by Refractometry
173
1484
1.21
1.41
6.0
4.2
kg/l
1.0
1.0
0.12
18
209
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
40
2.26
1.40
1.7
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
40
2.26
1.40
1.7
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
23
142
1.64
1.39
4.1
2.4
%
15.0
15.5
0.19
13
67
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
74
1.91
1.39
1.1
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
29
2.43
1.39
1.3
1.1
—
—
—
0
0
(4034850)
33
223
1.50
1.38
24.0
10.5
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
9
41
2.21
1.37
1.3
1.4
—
54.0
—
0
5
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
96
775
1.27
1.36
3.2
4.0
ug/l
23.5
19.0
0.08
82
661
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
68
1.93
1.34
1.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
68
1.93
1.34
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
68
1.93
1.34
1.5
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
13
68
1.93
1.34
2.7
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
88
706
1.28
1.32
2.0
2.0
ug/g
171.3
130.0
0.33
64
561
(3002385) Erythrocyte distribution width [Ratio]
563
5336
1.17
1.31
28.2
19.2
%
14.0
13.8
1.74
550
5226
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
6
24
2.51
1.30
1.0
2.0
nmol/l
1.4
1.0
—
6
19
(3004716) Salmonella sp identified in Stool by Organism specific culture
42
302
1.41
1.30
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
39
277
1.43
1.29
1.6
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
18
2.79
1.28
1.2
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
18
2.79
1.28
2.2
2.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
84
1.80
1.27
2.1
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
84
1.80
1.27
2.1
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
23
146
1.59
1.27
2.8
1.2
e6/l
2.1
34.1
0.87
18
117
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
421
0.68
1.26
1.5
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
14
77
1.83
1.26
1.1
1.3
nmol/l
0.5
0.6
0.73
14
71
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.5
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.5
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.5
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
36
2.23
1.24
1.5
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
85
1.78
1.23
2.1
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
85
1.78
1.23
2.0
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
45
2.01
1.23
2.2
2.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
56
1.98
1.22
2.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
19
2.64
1.21
1.2
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
19
2.64
1.21
1.2
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
26
2.32
1.19
1.0
1.1
iu/ml
169.2
175.8
—
6
26
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
38
2.12
1.18
1.1
1.8
—
—
—
0
0
(4146454)
14
79
1.79
1.17
3.0
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
25
166
1.52
1.16
1.6
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
20
2.51
1.15
1.4
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
45
338
1.35
1.10
1.4
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
31
2.27
1.10
1.4
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
23
152
1.53
1.10
1.3
1.2
u/ml
5.3
5.8
—
6
24
(3035637) Corticotropin [Mass/volume] in Plasma
12
66
1.83
1.09
1.6
1.6
—
—
—
0
0
(3048879) Bone marrow aspiration report
5
21
2.39
1.09
1.2
2.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
26
177
1.48
1.09
1.8
1.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
32
2.20
1.08
1.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
32
2.20
1.08
1.0
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
60
1.84
1.03
2.3
2.0
%
8.3
10.8
1.20
11
60
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
7
34
2.07
1.03
2.0
2.2
e9/l
0.4
0.2
—
7
29
(40768797) Stomach Pathology biopsy report
108
916
1.21
1.01
1.3
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
7
35
2.01
1.00
2.0
2.2
e6/l
416.3
497.5
—
7
29
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
37
275
1.36
0.99
1.2
1.9
u/l
35.6
38.6
0.44
30
244
(3025159) Blasts/100 leukocytes in Blood
61
489
1.27
0.97
7.2
4.0
%
0.7
0.8
0.03
23
129
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
48
373
1.30
0.96
2.9
2.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
51
1.77
0.94
1.1
1.2
—
60.0
—
0
9
(3008401) Mugwort IgE Ab [Units/volume] in Serum
11
62
1.78
0.94
1.0
1.1
u/ml
0.3
0.5
—
5
28
(3022806) Fractional oxyhemoglobin in Capillary blood
15
93
1.62
0.94
2.5
1.9
%
91.3
89.6
0.91
15
93
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
52
411
1.28
0.93
16.9
9.6
—
—
—
0
0
(4268621)
9
52
1.74
0.92
1.8
2.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
22
151
1.47
0.91
1.3
1.2
u/ml
2.5
2.9
—
6
19
(21494755) Public health laboratory ask at order entry panel
31
415
0.74
0.90
1.4
1.4
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
14
87
1.62
0.88
2.4
2.4
u/ml
5.9
48.5
0.46
14
82
(3035320) C reactive protein [Mass/volume] in Body fluid
8
43
1.87
0.87
4.6
2.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
205
1856
1.14
0.86
4.6
4.4
%
23.6
21.4
1.26
104
893
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
44
1.83
0.86
1.1
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
31
1.94
0.84
2.3
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
45
1.79
0.84
1.0
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
45
1.79
0.84
1.0
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
44
346
1.29
0.83
1.4
1.2
iu/ml
178.4
142.5
0.23
18
139
(3000492) Spirometry study
69
573
1.22
0.83
1.5
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
105
1.53
0.82
2.1
2.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
56
456
1.24
0.80
1.2
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
147
1.44
0.80
2.6
4.1
mg/l
13.1
27.4
3.32
15
99
(3024980) IgG subclass 4 [Mass/volume] in Serum
14
90
1.56
0.78
1.3
1.6
g/l
0.5
0.8
—
9
67
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
3.4
—
29.3
—
0
19
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
101
876
1.17
0.77
1.4
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
25
183
1.38
0.76
3.4
4.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
24
2.09
0.74
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
21
150
1.41
0.74
3.5
2.0
g/l
122.3
126.0
0.22
16
107
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
25
2.01
0.72
2.8
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
108
0.55
0.72
2.8
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
10
60
1.67
0.72
1.0
1.0
—
1.7
—
0
11
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
26
1.93
0.70
1.2
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.6
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.6
2.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
59
1.53
0.68
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
28
1.79
0.66
1.6
2.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
28
215
1.31
0.66
2.2
1.3
g/l
1.2
1.2
0.10
28
204
(4010399)
56
469
1.21
0.65
1.5
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
41
332
1.25
0.65
1.7
1.6
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
22
163
1.36
0.64
1.2
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
22
163
1.36
0.64
1.2
1.3
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
63
1.59
0.62
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
189
1742
1.11
0.60
4.7
3.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
51
1.57
0.60
1.5
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
17
122
1.40
0.60
1.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
20
148
1.36
0.60
1.7
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
27
210
1.30
0.59
2.1
1.4
g/l
0.2
0.2
0.20
27
200
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
11
72
1.53
0.59
1.0
1.1
u/ml
0.4
1.6
—
5
35
(3023410) Appearance of Cerebral spinal fluid
10
64
1.57
0.58
3.7
1.3
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
13
185
0.70
0.58
13.8
6.6
mmol/l
104.8
105.3
0.12
13
168
(3039000) Anion gap in Blood
13
185
0.70
0.58
13.8
6.6
mmol/l
10.8
11.3
0.23
13
168
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
53
1.51
0.58
2.0
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
57
667
0.84
0.58
1.6
1.7
%
1.5
1.5
0.13
49
578
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
6
35
1.72
0.57
4.3
2.9
u/l
161.8
214.5
—
6
35
(40768795) Lymph node Pathology biopsy report
8
54
1.49
0.57
1.6
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
54
1.49
0.57
1.4
1.3
—
—
—
0
0
(4024509)
10
65
1.54
0.55
1.9
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
48
404
1.20
0.55
1.2
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
83
734
1.15
0.53
4.9
3.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
108
1.40
0.53
3.3
2.9
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
39
1.54
0.53
3.7
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
146
0.68
0.52
1.1
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
53
453
1.18
0.52
3.9
3.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
63
1.43
0.52
6.8
3.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
40
1.50
0.51
3.3
3.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
6
40
1.50
0.51
1.7
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
6
41
1.47
0.50
1.7
2.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
41
1.47
0.50
2.3
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
12
84
1.43
0.49
1.3
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
13
93
1.40
0.48
1.3
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
46
1.53
0.48
1.4
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
12
85
1.42
0.47
1.4
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
85
1.42
0.47
1.2
1.4
e6/l
14479.2
16607.7
—
6
50
(3039443) Prostate specific Ag panel - Serum or Plasma
8
121
0.66
0.45
1.9
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
174
1.27
0.45
1.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
166
1.27
0.43
1.4
1.3
—
—
—
0
0
(4027681)
5
31
1.62
0.43
1.0
1.2
—
—
—
0
0
(4062490)
8
57
1.41
0.42
1.4
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
167
1.26
0.42
1.6
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
79
1.40
0.41
1.6
2.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
17
0.00
0.40
0.0
1.5
—
20.7
—
0
12
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
18
141
1.28
0.40
2.7
1.6
iu/l
2.5
5.6
—
9
41
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
34
1.47
0.40
1.8
3.8
nmol/l
105.4
119.9
—
5
34
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
43
372
1.16
0.39
2.0
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
71
1.41
0.39
1.3
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
106
0.66
0.39
1.1
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(4281824)
9
68
1.33
0.37
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
147
0.74
0.37
1.1
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
72
1.39
0.37
1.2
1.3
nmol/l
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
72
1.39
0.37
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
72
1.39
0.37
1.1
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
146
0.75
0.36
1.1
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
11
146
0.75
0.36
1.1
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
6
43
1.40
0.35
1.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
73
1.37
0.34
2.9
2.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
44
1.37
0.34
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
35
302
1.17
0.34
2.7
2.8
—
—
—
0
0
(1002224) Polysomnography panel
18
221
0.81
0.34
1.1
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
45
1.34
0.34
1.3
1.3
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
10
74
1.36
0.32
1.1
1.1
g/l
1.3
1.5
—
10
65
(3035880) pH of Pleural fluid
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
141
1329
1.07
0.30
3.4
3.1
ug/l
0.8
0.8
0.17
98
882
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
93
1.29
0.30
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
47
421
1.12
0.29
2.1
2.0
nmol/l
13.0
13.0
0.00
40
371
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
58
636
0.91
0.28
1.8
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
194
0.82
0.28
1.4
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
84
782
1.08
0.26
1.5
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
75
1.20
0.25
1.2
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
17
142
1.20
0.24
2.8
3.5
u/ml
225.5
2602.0
0.73
17
133
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
38
423
0.89
0.24
1.1
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
11
137
0.80
0.24
1.3
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
16
133
1.21
0.24
1.8
1.7
nmol/l
46.8
40.7
0.39
16
127
(3051651) Icteric interference index of Serum or Plasma
5
38
1.32
0.23
7.4
3.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
17
200
0.85
0.23
1.6
1.6
mg/l
1.4
3.0
1.40
12
147
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
40
1.25
0.22
1.0
1.0
—
0.7
—
0
10
(3006653) Thiamine [Moles/volume] in Blood
5
41
1.22
0.22
1.4
1.2
nmol/l
172.2
143.8
—
5
41
(44813793)
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
1.2
—
0
5
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
102
0.78
0.21
1.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
18
154
1.17
0.21
1.7
2.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
105
0.76
0.21
1.8
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
0.5
—
0
6
(3014891) Appearance of Pleural fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
134
0.82
0.20
1.1
1.4
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.5
—
2.8
—
0
5
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
59
1.19
0.18
2.3
1.9
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
7
60
1.17
0.18
1.1
1.2
nmol/l
395.7
396.7
—
7
52
(3032773) Endomysium IgG Ab [Titer] in Serum
7
60
1.17
0.18
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
67
0.74
0.17
1.0
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
68
1.18
0.16
1.0
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
79
1.14
0.15
1.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
93
1.19
0.14
1.5
1.8
pmol/l
159.4
218.3
1.18
11
86
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
84
1.19
0.14
1.4
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
8
100
0.80
0.13
1.0
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
152
1.12
0.12
1.6
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
27
290
0.93
0.10
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
198
2019
0.97
0.10
3.5
2.9
—
—
—
0
0
(3017704) Immunofixation for Urine
5
46
1.09
0.09
1.4
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
87
1.15
0.09
1.3
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
32
301
1.07
0.09
3.7
3.2
u/ml
727.7
4742.9
0.63
27
259
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
21
194
1.08
0.09
1.9
2.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
44
422
1.04
0.07
2.2
2.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
206
1.07
0.07
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
15
163
0.92
0.07
1.9
2.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
89
1.13
0.07
3.3
3.8
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
11
99
1.11
0.06
1.1
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
30
287
1.05
0.05
1.1
1.1
—
104.2
—
0
5
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
110
0.91
0.05
2.9
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
11
119
0.92
0.04
1.0
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
33
319
1.04
0.03
7.7
5.1
%
1.4
1.6
0.80
33
299
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
181
1.05
0.03
1.8
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
21
202
1.04
0.02
5.7
4.8
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
12
126
0.95
0.00
1.3
1.4
—
—
—
0
0
(4094501)
16
156
1.03
0.00
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
37
375
0.99
0.00
4.0
3.7
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
13
128
1.02
0.00
1.2
1.5
pmol/l
163.8
379.7
0.86
13
128
(3027456) Digoxin [Moles/volume] in Serum or Plasma
22
222
0.99
0.00
3.0
3.3
nmol/l
0.8
0.8
0.13
15
176
(3007930) Methemoglobin/Hemoglobin.total in Blood
32
318
1.01
0.00
7.3
5.1
%
0.8
0.9
1.13
32
299
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
1.9
—
0
5
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
183.0
—
0
5
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
8
86
0.93
0.00
1.6
5.1
umol/l
337.9
357.4
—
8
79
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
5
51
0.98
0.00
1.6
1.5
u/l
9.4
33.4
—
5
41
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H7_RETINAHAEMORR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_RETINAHAEMORR | 0.987 [0.87, 1.12] | 0.838 |
| Birth year | 0.998 [0.99, 1.01] | 0.6 |
During the follow-up period (1.1.1998 — 31.12.2019), 1022 out of 3021 females with H7_RETINAHAEMORR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_RETINAHAEMORR | 1.254 [1.05, 1.49] | 0.011 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 664 out of 2055 males with H7_RETINAHAEMORR died.
Mortality risk
Mortality risk for people of age
years, who have H7_RETINAHAEMORR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.073% | 0.242% |
| 5 | 0.625% | 1.341% |
| 10 | 1.745% | 3.327% |
| 15 | 3.176% | 6.081% |
| 20 | 5.491% | 10.27% |
Relationships between endpoints
↥Index endpoint: H7_RETINAHAEMORR – Retinal haemorrhage
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data